EW
Edwards Lifesciences Corporation · Healthcare · Medical - Devices
Señales de momentum (gestores comparables):
amplitud de titulares -4.8% ·
flujo de acciones -2.9% ·
nuevas posiciones netas -5.0%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 14.87M | $1.28B | n/a | n/a |
| Q2 2026 | 163 | -6 | 423.46M | $38.23B | +2 | −9 |
| Q1 2026 | 173 | +2 | 408.99M | $32.75B | +6 | −5 |
| Q4 2025 | 170 | 0 | 441.50M | $37.63B | +2 | −1 |
| Q3 2025 | 24 | -1 | 280.60M | $21.82B | +1 | −3 |
| Q2 2025 | 23 | 0 | 232.09M | $18.15B | n/a | n/a |
| Q1 2025 | 20 | -1 | 112.98M | $8.18B | n/a | −1 |
| Q4 2024 | 21 | +1 | 116.40M | $8.61B | +1 | n/a |
| Q3 2024 | 19 | +1 | 77.58M | $5.12B | +2 | −1 |
| Q2 2024 | 18 | n/a | 60.09M | $5.55B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 29.13M | -12.3% | $2.11B | 0.4% | ▼ Trim | 4 | SEC ↗ ×9 |
| 2 | State Street Global Advisors ✦ (pasivo) | 25.78M | -0.1% | $1.87B | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 13.38M | +42.1% | $969.90M | 1.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Geode Capital Management ✦ (pasivo) | 12.68M | -7.1% | $915.38M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 5 | Fisher Asset Management ✦ | 10.10M | +3.3% | $732.08M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 6 | Norges Bank ✦ (pasivo) | 6.49M | -21.3% | $470.54M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 7 | Millennium Management ✦ | 3.44M | +1409.8% | $249.68M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 8 | Marshall Wace ✦ | 3.03M | -47.9% | $219.66M | 0.3% | ▼ Trim | 4 | SEC ↗ ×3 |
| 9 | PRIMECAP Management ✦ | 2.30M | +12.5% | $166.68M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 1.47M | +149.7% | $106.45M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 1.01M | +54.3% | $72.96M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 918.54K | +339.7% | $65.38M | 0.1% | ▲ Add | 4 | SEC ↗ ×6 |
| 13 | D. E. Shaw & Co. ✦ | 874.41K | -10.5% | $63.38M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 14 | T. Rowe Price ✦ | 859.69K | -73.9% | $62.31M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 15 | Baillie Gifford ✦ | 581.44K | -17.7% | $42.14M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 16 | Adage Capital Partners ✦ | 453.27K | -63.0% | $32.85M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 266.06K | +478.5% | $19.28M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 97.10K | -22.3% | $7.04M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 62.52K | -42.3% | $4.53M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 43.66K | +165.8% | $3.16M | 0.0% | ▲ Add | 4 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Soros Fund Management | $18.51M | era 0.5% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 4 tenedores, 229.24K acciones, $319,498 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 619 acc. · $53,017
Officer · 619 acc. · $54,169
Officer · 544 acc. · $49,534
Officer · 2.64K acc. · $237,907
Officer · 1.24K acc. · $113,417
Officer · 1.15K acc. · $105,893
Officer · 30.65K acc. · $2.79M
Officer · 619 acc. · $56,967
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología